Prospective Gallbladder Database STGAG

Organizational Data

DRKS-ID:
DRKS00033085
Recruitment Status:
Recruiting planned
Date of registration in DRKS:
2023-11-30
Last update in DRKS:
2024-02-05
Registration type:
Prospective

Acronym/abbreviation of the study

GB-DB-TG

URL of the study

https://www.stgag.ch/fachbereiche/chirurgie/forschung/

Brief summary in lay language

Cholecystectomy represents the most important pillar of treating gallstone-associated diseases. High-quality surgical treatment must be ensured and quality must be measured. Therefore, all patients who are operated on in our center should be systematically recorded and the surgical efficiency and safety should be prospectively examined. This is the only way to ensure constant benchmarking and quality improvement.

Brief summary in scientific language

The primary objective is to gain data which allow a local surgical quality assurance and benchmarking in order to identify factors which can be improved. This is a long-term objective and therefore the project’s time-line is open. However, due to its exploratory character there is no formal hypothesis or primary endpoint.

Health condition or problem studied

Free text:
Benign diseases of the gallbladder or other diseases caused by gallstones
Healthy volunteers:
No

Interventions, Observational Groups

Arm 1:
Gallbladder surgery

Endpoints

Primary outcome:
Quality control and benchmarking
Secondary outcome:
Intraoperative endpoints Date of surgery Elective surgery or emergency operation For elective: Inpatient or outpatient Preoperative ERCP Operative time (Time from incision of skin until skin closure, in minutes) Intraoperative blood loss (measured in ml) Insertion of drainage (yes/no) Type of procedure Open resection Laparoscopic resection Robot-assisted Conversion to open resection Cholangiography (y/n) Obstruction of bile duct (y/n) Intervention due to obstruction Transcystic Fogarty catheter Choledochotomy Other Surgeon (Resident, Consultant (supervised or not), Senior surgeon) Identification of the critical view of safety possible (y/n) Documentation with Photo Closing of gallbladder artery With clips With coagulation With stapler Closing of gallbladder duct With clips With coagulation With stapler Intraoperative Complications Gallbladder perforation (=bile spilling) Lesion of common bile duct Strasberg classification Biliodigestive anastomosis (yes/no) Suture T-Drainage Stent Lesion of other intra-abdominal organ Bleeding with need of additional intervention (beamer, haemostyptic or other) Other complications Postoperative endpoints Postoperative complications (Clavien-Dindo classification) within 14 days, especially Postoperative hemorrhage Bile leakage Intra-abdominal fluid collection Choledocholithiasis Re-intervention rate Up to 14 days after surgery Re-operation rate Up to 14 days after surgery Surgical site infection (according to CDC definition) Pain on a numeric rating scale Evaluated at 4h, 48h, 14 days after Surgery Postoperative nausea and vomiting Evaluated at 4h, 48h, 14 days after Surgery Length of hospital stay (LOS, days from the day of the index operation until the day of hospital discharge; 0 = outpatient surgery) Prolonged hospitalization ((y/n; >2 days for inpatient and >0 for outpatient surgery) If yes, due to Pain Nausea and vomiting Bleeding Wound complications Social reasons Other Re-admission rate, up to 14 days after surgery If yes, due to Pain Nausea and vomiting Bleeding Wound complications Social reasons Other Visits to the emergency room after discharge, up to 14 days after surgery Date (which postoperative day) If yes, due to Pain Nausea and vomiting Bleeding Wound complications Social reasons Other Time to return to work (in days) Evaluated at 14 days after surgery Histological examination The Gastrointestinal Quality of Life Index (GIQLI), 14 days after surgery Case costs First admission Income Expenses In case of readmission Income Expenses In case of mortality: reason and explanation

Study Design

Purpose:
Treatment
Retrospective/prospective:
Prospective
Study type:
Non-interventional
Longitudinal/cross-sectional:
Longitudinal study
Study type non-interventional:
Patient Registry

Recruitment

Recruitment Status:
Recruiting planned
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Switzerland
Number of study centers:
Multicenter study
Recruitment location(s):
  • Medical center Chirurgie STGAG Frauenfeld
  • Medical center Chirurgie STGAG Münsterlingen

Recruitment period and number of participants

Planned study start date:
2024-08-01
Actual study start date:
No Entry
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
9999
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
All patients undergoing a treatment for a benign disease of the gallbladder or other gallstone-associated diseases.

Exclusion Criteria

Malignant diseases.

Addresses

Primary Sponsor

Address:
Chirurgie STGAG
Pfaffenholzstrasse 4
8501 Frauenfeld
Switzerland
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Chirurgie STGAG
Prof. Dr. med. Pascal Probst
Pfaffenholzstrasse 4
8501 Frauenfeld
Switzerland
Telephone:
+41 58 144 7241
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Chirurgie STGAG
Prof. Dr. med. Pascal Probst
Pfaffenholzstrasse 4
8501 Frauenfeld
Switzerland
Telephone:
+41 58 144 7241
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Chirurgie STGAG
Prof. Dr. med. Pascal Probst
Pfaffenholzstrasse 4
8501 Frauenfeld
Switzerland
Telephone:
+41 58 144 7241
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Chirurgie STGAG
Pfaffenholzstrasse 4
8501 Frauenfeld
Switzerland
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission Ostschweiz (EKOS)
Scheibenackerstrasse 4
9000 St. Gallen
Switzerland
Telephone:
+41 58 411 28 95
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.sg.ch/gesundheit-soziales/gesundheit/gremien.html

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2023-10-26
Ethics committee number:
2023-01967
Vote of the Ethics Committee:
No approval required according to the EC
Date of the vote:
2023-11-02

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
Yes
IPD Sharing Plan:
Surgical researchers can make a request to have the data made available. Both the patient data and all supporting information (e.g. study protocol, statistical analysis plan etc.) can be applied for. For this purpose, a written request must be made to the primary investigator with a description of the research project for which the data is to be used. Possible analyzes that would be supported would be multi-center retrospective analyzes or IPD meta-analyses. However, the data will only be shared after the point in time at which they were primarily published by STGAG and a maximum of ten years after the data was recorded. If the study director decides to make the data available, they will be transmitted in a processable form and anonymously.

Study protocol and other study documents

Study protocols:
Protokoll für die Ethik, 2023
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry